| 翻訳と辞書 |
| Medicines for Malaria Venture (MMV) ： ウィキペディア英語版 |
Medicines for Malaria Venture
Medicines for Malaria Venture (MMV), a not-for-profit public-private partnership, was established as a foundation in Switzerland in 1999. Its mission is to reduce the burden of malaria in disease-endemic countries by discovering, developing and facilitating delivery of new, effective and affordable antimalarial drugs. Its vision is a world in which these innovative medicines will cure and protect the vulnerable and under-served populations at risk of malaria, and help to ultimately eradicate this terrible disease.
==History==
MMV was launched in 1999, with initial seed finance of US$4 million from the Government of Switzerland, Department for International Development (UK), the Government of the Netherlands, The World Bank, and Rockefeller Foundation.
In 1999, the pipeline for new antimalarial drugs was virtually empty. The possibility of profit in antimalarial drug development was considered too low to attract pharmaceutical investment. Malaria was killing 1-2 million people a year, most of them children under five and pregnant women from the poorest regions of the world.
The drugs they were using no longer worked, and the need to act in the face of a projected public health disaster due to escalating drug resistance, provided reason to launch MMV and has since proved that the public-private partnership model is an efficient way to bridge the gap in new drugs for malaria.
抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』
■ウィキペディアで「Medicines for Malaria Venture」の詳細全文を読む
スポンサード リンク
| 翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|